MYC and neoplasm: Thus, c-Myc as a molecular target must be approached with caution as majority of tumor cells may demonstrate a limited therapeutic response, but a critical tumor population such as CSCs and/or EMT changes may be inhibited or killed to improve overall tumor control and decrease resistance to therapies.